Loading…

Loading grant details…

Active NON-SBIR/STTR RPGS NIH (US)

A Biological Theory of Attention Control in the Framework of Rational Meta-Reasoning

$3.56M USD

Funder NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
Recipient Organization Columbia University Health Sciences
Country United States
Start Date Aug 01, 2024
End Date Jun 30, 2026
Duration 698 days
Number of Grantees 2
Roles Co-Investigator; Principal Investigator
Data Source NIH (US)
Grant ID 10888011
Grant Description

Summary Attending to informative stimuli is critical for choosing appropriate actions, but the biological mechanisms underlying this ability are not well understood. Recent theoretical models of computational rationality propose that an executive meta-level controller regulates the precision of a cognitive process (e.g., learning or memory)

based on the estimated costs and benefits of the process in a particular context. However, current models have yet to account for the control of attention to obtain information (reduce uncertainty) and have been limited to mathematical formalisms rather than biologically plausible architectures. In a Targeted BRAIN Circuits R01, we

will fill these gaps by investigating the cellular and neuromodulatory mechanisms of attention control in visual and executive structures – i.e., the monkey lateral intraparietal area (LIP) and anterior cingulate cortex (ACC) – in conjunction with a neurocognitive model developed by the PIs, the attention reinforcement meta-learner (A-

RML). We will test the novel hypotheses that (1) stimuli compete for control of saccades based on their diagnosticity (predictive accuracy about future events) and the competition is sharpened in favor of more diagnostic predictors by higher decision uncertainty and (2) dACC and LIP, and DA and NE have distinct roles

in, respectively, the valuation and implementation of an attentional policy. In the current planning proposal, we set the stage for this goal providing behavioral evidence for our hypothesis (Aim 1), and (2) establishing the feasibility of using, in monkeys, novel fluorescent molecular sensors – GRAB – that have been demonstrated in

rodents to measure neurotransmitter release with much greater temporal and pharmacological specificity relative to current techniques (Aim 2). In the full RO1 we will use these tools to obtain high precision measurements of neuromodulator release in relation to information gathering and neural activity, validate and further extend the

A-RML based on empirical observations, and interrogating the circuit using causal manipulations. The results will provide a novel account of attention control that spans cellular and neuromodulatory mechanisms and a computational account linking attention with Bayesian theories of uncertainty minimization.

All Grantees

Columbia University Health Sciences

Advertisement
Apply for grants with GrantFunds
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant